CYC vs IBX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

41LOW

IBX

IMAGIONBIO FPO [IBX]

28LOW

Score Breakdown

CYC IBX
Technical
41
35
Catalyst
51
53
Sentiment
50
50
Fundamental
69
17
Momentum
39
25
Risk Gate
50
27

Key Metrics

CYC Metric IBX
$61.6MMarket Cap$6.5M
345KAvg Volume (20d)2.6M
N/AShort InterestN/A
$1.29052-Week High$0.055
$0.45052-Week Low$0.011
-6.7%Daily Change+0.0%
$0.490Reference Price$0.011
-49.3%ROEN/A
-53.3%Profit MarginN/A

Active Signals

CYC Signals

RSI drifting toward oversold territory — worth watching
Volume surging at 2.7x normal while price falls — heavy selling pressure
Watch out — volume is flowing out even as price holds up. Distribution pattern
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.5 quarters)
Low P/S ratio (1.9x)
Moderate revenue growth (+10%)
EPS estimates revised upward (+10pts)

IBX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Above-average volume (1.8x) on a red day — sellers in control
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Sitting near support — this level has held before and could attract buyers again
Took a hit — down 15.4% over the last 5 days

Ask Scout AI to compare CYC and IBX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CYC vs IMR →CYC vs MVF →CYC vs NEU →CYC vs PHX →CYC vs PKY →
CYC Full Analysis → IBX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).